Lastly, the expression of TF has been shown to induce tumor angiogenesis in colorectal cancer and breast cancer models through TF-fVIIa-dependent PAR-2 activation [105–107], which induces the expression of VEGF, IL-8, MMP-7, and CXCL-1. Here, TF is linked to breast carcinoma.